SUBSCRIBE
SUBSCRIBE
News   Business

Raptor Pharmaceutical Inc. Reports Financial Results for the Transition Period From September 1, 2012 to December 31, 2012

March 15, 2013 | 
1 min read
NOVATO, Calif., March 14, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today reported financial results for its four month transition period from September 1, 2012 to December 31, 2012.
Earnings
MORE ON THIS TOPIC
The path to precision. The road to the center of the target. The concept of goal achievement, precision, strategic direction, and focus on results. Polygonal design, blue background.
Deals
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’
April 28, 2026
 · 
2 min read
 · 
Gabrielle Masson
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
April 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.
Venture capital
Big Pharma–backed Coultreon bags $125M series A to unlock alternative immune pathway
April 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Abstract Weather Concept - Sun In Serene Sky With Flare Effect
Deals
Sun Pharma beams up Organon in $11.75B acquisition
April 27, 2026
 · 
1 min read
 · 
Gabrielle Masson